CLSI M39 A2 : 2ED 2005

Abstract
Committee Membership
Foreword
1 Scope
2 Introduction
3 Definitions
4 Information System Design
  4.1 Data Export or Transmission
  4.2 Desirable Attributes of the Data Analysis System
  4.3 Patient Demographic Information
  4.4 Specimen Information
  4.5 Organism Information
  4.6 Antimicrobial Susceptibility Test Information
5 Data Analysis
  5.1 Data Verification
  5.2 Facility
  5.3 Frequency
  5.4 Isolates
  5.5 Antimicrobial Agents
  5.6 Calculations
  5.7 Validation of Calculations
  5.8 Supplemental Analyses and Selection Criteria
6 Data Presentation
  6.1 Items to Be Considered in Constructing the Table
  6.2 Items to Be Considered With Specific Tables
  6.3 Other Presentation Options
7 Use of Cumulative Antimicrobial Susceptibility Reports
  7.1 Use of the Report
  7.2 Distribution of the Report
8 Limitations of Data, Data Analysis, and Data Presentation
  8.1 Culturing Practices
  8.2 Influence of Small Numbers of Isolates
  8.3 Comparison of Individual Antimicrobial Agent Results
  8.4 Identification of New Patterns of Resistance
9 Statistical Significance of Changes in Susceptibility Rates
Bibliography
Appendix A. Suggestions for Verification of Antimicrobial
            Susceptibility Test Results and Confirmation
            of Organism Identification
Appendix B. Rationale Behind the "First Isolate Per Patient"
            Analysis Recommendation
Appendix C. Example of Using a Line Listing to Verify
            Susceptibility Rates Determined by the Analysis
            Software
Appendix D. Cumulative Antimicrobial Susceptibility Report
            Example (Hypothetical Data)
Appendix E. Example of Graph to Illustrate Trend in
            Susceptibility Over Five Years
Appendix F. Steps for Presenting Local Cumulative Antibiogram
            Report to Healthcare Professionals
Appendix G. Aid to Determine the Statistical Significance of
            Change in %S
Appendix H. Glossary I (Part 1). (Beta)-lactams: Class and
            Subclass Designation and Generic Name
            Glossary I (Part 2). Non-(Beta)-lactums: Class and
            Subclass Designation and Generic Name
            Glossary II. Abbreviations/Routes of Administration/Drug
            Class for Antimicrobial Agents
The Quality System Approach
Related CLSI/NCCLS Publications

Specifies the methods for recording and analysis of antimicrobial susceptibility test data, consisting of cumulative and ongoing summaries of susceptibility patterns of clinically significant micro organisms.